Daptomycin 70594-0053-01
- Manufacturer
- Xellia Pharmaceuticals Usa Llc
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- March 15, 2019
- Listing Expires
- December 31, 2026
- Application
- NDA209949
Need to source Daptomycin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Daptomycin | 350 mg/7mL |
Drug Class
Lipopeptide Antibacterial [EPC]Lipopeptide Antibacterial [EPC]Lipopeptides [CS]
Selected Package
70594-0053-01Selected1 VIAL, SINGLE-USE in 1 CARTON (70594-053-01) / 7 mL in 1 VIAL, SINGLE-USE